Lexus India Limited

Lexus India Limited

Manufactures and repairs gold and silver jewelry, cutlery, and gifts since 1992.
1992 | New Delhi, Delhi (India) | Under Insolvency

Last Updated:

July 25, 2024
HomeCompanyLexus India Limited

Who are the key members and board of directors at Lexus India?

Executive Team (1)

NameDesignationAppointment DateStatus
Pramod Saraf InManaging Director30-Nov-2000Current

Board Members(4)

NameDesignationAppointment DateStatus
Shubham Saraf In Director 30-Apr-2018Current
Kusum Saraf In Director 15-May-2002Current
Sandeep Kandoi In Director Current
Satish Agarwal In Director Current

Financial Performance of Lexus India.

Lexus India Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 68.61% decrease. The company also saw a substantial fall in profitability, with a 291.89% decrease in profit. The company's net worth observed a substantial decline by a decrease of 34.23%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-68.61%
Revenue from Operations
-68.64%
Total Assets
2.71%
Profit or Loss
-291.89%
Net Worth
-34.23%
EBITDA
-1335.34%

Related Corporates (Common Directorship)

Charges (Loans)

Open Charges

₹6.60 Cr

LenderAmountStatus

Bank Of India

Creation Date: 13 Oct 2007
₹2.00 CrOpen

Small Industries Development Bank Of India

Creation Date: 11 Nov 2006
₹4.60 CrOpen

How Many Employees Work at Lexus India?

Unlock and access historical data on people associated with Lexus India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Lexus India

Recent activity within the organization

  • Annual General Meeting

    Lexus India Limited last Annual general meeting of members was held on 18 Dec 2023 as per latest MCA records.

    18 Dec 2023

  • Balance Sheet

    Lexus India Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.

    31 Mar 2023

  • Director Appointment

    Shubham Saraf was appointed as a Director was appointed as a Director on 30 Apr 2018 & has been associated with this company since 6 years 7 months .

    30 Apr 2018

  • Charges

    A charge with Bank Of India of Rs. 2.00 Cr registered on 13 Oct 2007 with Charge ID 10076748 was modified on 06 Apr 2010.

    06 Apr 2010

  • Charges

    A charge with Bank Of India amounted to Rs. 2.00 Cr with Charge ID 10076748 was registered on 13 Oct 2007.

    13 Oct 2007

  • Charges

    A charge with Small Industries Development Bank Of India amounted to Rs. 4.60 Cr with Charge ID 90333931 was registered on 11 Nov 2006.

    11 Nov 2006

Recent News, Updates & Announcement

Frequently asked questions

  • Lexus India Limited was incorporated on 01 Jun 1992.

  • The authorized share capital of Lexus India Limited is ₹ 4.00 Cr and paid-up capital is ₹ 3.23 Cr.

  • Currently 5 directors are associated with Lexus India Limited.

    • Shubham Saraf
    • Kusum Saraf
    • Sandeep Kumar Kandoi
    • Satish Agarwal
    • Pramod Kumar Saraf
  • As per Ministry of Corporate Affairs (Mca), the registered address of Lexus India Limited is H-25 First Floor Kailash Colony, New Delhi, India, 110048.

  • The corporate identification number (CIN) of Lexus India Limited is U51909DL1992PLC048996 and the company number is 048996 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2023, the revenue trend for Lexus India Limited has fallen by -68.61%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Lexus India Limited has experienced an downturn of -34.23%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Lexus India Limited amount to ₹ 6.60 Cr.

  • The most recent Balance Sheet for Lexus India Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development